Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Yum China Holdings Inc (YUMC) Price & Performance

Cassava Sciences IncTrade
Yum China Holdings IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Yum China Holdings Inc — how do they compare? Cassava Sciences Inc trades at $0.94 (market cap $47.75M), while Yum China Holdings Inc trades at $47.8 (market cap $16.28B). The key difference: Yum China Holdings Inc is far larger — about 340.9× Cassava Sciences Inc's market cap, and Yum China Holdings Inc pays a 2.44% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FLNAYUMC
Market Cap
$47.75M$16.28B
Sector
HealthConsumer Cyclical
52-Week High
$4.64$57.95
52-Week Low
$0.87$40.18
Enterprise Value
-$34.93M$17.19B
Dividend Yield
2.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9528, down 4.46% today, with a bearish technical outlook but strong analyst support (66.7% buy ratings). The company continues to post net losses and negative cash flows, though recent EPS beats show some operational improvement. Recent news highlights Q2 2026 results and business updates on Tuberous Sclerosis Complex therapies.

The outlook remains speculative due to persistent unprofitability and cash burn, but analyst optimism and a low P/B ratio of 0.75 may attract value investors. Key risks include execution challenges in drug development and reliance on financing amid negative earnings.

Yum China Holdings Inc

YUMC trades at $47.77, down 0.87% today, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating estimates, and revenue growth of 13% year-over-year. Recent completion of the Pizza Hut brand acquisition in Mainland China for $1.2 billion enhances strategic control and potential margin expansion.

Outlook remains positive with consistent earnings beats and analyst consensus favoring a buy rating. Key risks include macroeconomic headwinds in China and integration challenges from the acquisition. The stock offers growth potential with a reasonable P/E of 17.43 and a projected 26.2% upside based on Wall Street targets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Yum China Holdings Inc

With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.

Read more on YUMC